Evidence for the tumor necrosis factor/cachectin production in cancer. 1988

R M Fine
Department of Dermatology, Emory University School of Medicine, Decatur, Georgia.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

R M Fine
November 1987, Lancet (London, England),
R M Fine
January 1990, Acta haematologica Polonica,
R M Fine
June 1996, JPMA. The Journal of the Pakistan Medical Association,
R M Fine
November 1985, Lancet (London, England),
R M Fine
March 1989, Revista clinica espanola,
R M Fine
January 1991, Revue roumaine de virologie (Bucharest, Romania : 1990),
R M Fine
December 1985, Journal of immunology (Baltimore, Md. : 1950),
R M Fine
June 1987, Journal of clinical gastroenterology,
R M Fine
September 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R M Fine
February 1987, The New England journal of medicine,
Copied contents to your clipboard!